Vincent Pham Named an AACR Early-Career Scholar and to Present Cachexia Research at AACR Annual Meeting 2026

SAN ANTONIO, Texas — The Huang Lab at the Mays Cancer Center at UT Health San Antonio announces that Vincent Pham, Cancer Biology PhD Candidate, has been named an Early-Career Scholar by the American Association for Cancer Research (AACR) for the 2026 Annual Meeting in San Diego, California, held April 17 to 22. The award recognizes promising early-career investigators and supports their participation in the meeting.

Vincent will deliver two presentations on April 21, both centered on cancer-associated cachexia, the metabolic wasting syndrome that worsens outcomes across many cancers. His oral presentation in the minisymposium is titled "Estrogen therapy alleviates cancer-associated cachexia in mouse models of both sexes." His poster, board #4745, is titled "Tumor-intrinsic Warburg effect as the driver and therapeutic target for cancer-associated cachexia."

"Vincent's work connects tumor metabolism and hormonal biology to a syndrome that takes a real toll on patients," said Dr. Gang Huang, principal investigator. "Being selected as an Early-Career Scholar reflects both the quality of the science and his promise as an investigator."

"I am grateful for this recognition and excited to share our cachexia work with the field," said Vincent. "The feedback we gather at AACR will sharpen the next round of studies."

About the Huang Lab

The Huang Lab at UT Health San Antonio is a basic and translational cancer research group within the MD Anderson Mays Cancer Center at UT Health San Antonio. Our team integrates hematology and solid tumor biology with immunology and metabolism to uncover mechanisms and design interventions. We advance cell and biologic therapies, including CAR T-cell approaches for solid tumors. We also conduct research in trauma and military health. We move discoveries toward clinical impact through product development and collaborations with clinicians and industry. Education and mentorship are core to our mission. We train students, postdoctoral fellows, and early-career scientists in rigorous, multidisciplinary research. Together, we aim to deliver therapies and technologies that improve patient outcomes.